What is Bio-Techne's accrued expenses?

Bio-Techne (TECH) reported accrued expenses of $54.43M in Q1 2026.

How has Bio-Techne's accrued expenses changed year-over-year?

Bio-Techne's accrued expenses decreased by 12.1% year-over-year, from $61.9M to $54.43M.

What is the long-term trend for Bio-Techne's accrued expenses?

Over 4 years (2021 to 2025), Bio-Techne's accrued expenses has grown at a 6.4% compound annual growth rate (CAGR), from $51.29M to $65.79M.

Bio-Techne TECH Accrued Expenses

Accrued Expenses at other companies

DanaherDHR

$4.75B+7.3%

BrukerBRKR

$597.9M+1.0%

RevvityRVTY

$10.7M-10.1%

Bio-Rad LaboratoriesBIO

$148.4M-5.7%

Agilent TechnologiesA

$298M-20.3%

Charles River LaboratoriesCRL

$166.89M-15.4%

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's accrued expenses?: Bio-Techne (TECH) reported accrued expenses of $54.43M in Q1 2026.
How has Bio-Techne's accrued expenses changed year-over-year?: Bio-Techne's accrued expenses decreased by 12.1% year-over-year, from $61.9M to $54.43M.
What is the long-term trend for Bio-Techne's accrued expenses?: Over 4 years (2021 to 2025), Bio-Techne's accrued expenses has grown at a 6.4% compound annual growth rate (CAGR), from $51.29M to $65.79M.